Samuel Pichardo

About

Samuel Pichardo is a leading innovator in the field of therapeutic ultrasound, specializing in the development of MR-guided focused ultrasound (MRgFUS) robotic systems for noninvasive cancer and neurosurgical treatments. His major contributions include designing a groundbreaking C-shaped robotic platform for MRgFUS therapy of multiple cancer types—including breast, bone, thyroid, and abdominal tumors—enabling top-to-bottom treatment access within conventional MRI systems (2022, 20 citations). He also pioneered the first MR-conditional robot for transcranial focused ultrasound surgery in infants, targeting intraventricular hemorrhage (IVH) in premature neonates as a noninvasive alternative to invasive brain surgery (2016, 15 citations). Pichardo’s work extends to validating robotic MR-guided high-intensity focused ultrasound platforms for clot lysis in brain phantoms, demonstrating both efficacy and targeting accuracy for neonatal neurosurgery (2022, 5 and 4 citations). His research bridges engineering and clinical translation, offering safer, less invasive options for vulnerable populations. With a focus on precision and accessibility, Pichardo’s achievements position him at the forefront of pediatric and oncological focused ultrasound, impacting both device design and patient outcomes.

Research Focus

Key Achievements

Top Papers

1. 1
   Robotic system for top to bottom MRgFUS therapy of multiple cancer types

   20 citations · 2022
2. 2
   Design and validation of an MR‐conditional robot for transcranial focused ultrasound surgery in infants

   15 citations · 2016
3. 3
   A robotic MR-guided high-intensity focused ultrasound platform for intraventricular hemorrhage: assessment of clot lysis efficacy in a brain phantom

   5 citations · 2022
4. 4
   A robotic magnetic resonance‐guided high‐intensity focused ultrasound platform for neonatal neurosurgery: Assessment of targeting accuracy and precision in a brain phantom

   4 citations · 2022

Key Collaborators

Contact & Links